|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
PT1377314E
(pt)
|
2001-01-26 |
2012-01-02 |
Inhibitex Inc |
Anticorpos monoclonais para a proteína clfa e método de utilização no tratamento ou prevenção de infecções
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
US20030226155A1
(en)
|
2001-08-30 |
2003-12-04 |
Biorexis Pharmaceutical Corporation |
Modified transferrin-antibody fusion proteins
|
|
US20040014194A1
(en)
|
2002-03-27 |
2004-01-22 |
Schering Corporation |
Beta-secretase crystals and methods for preparing and using the same
|
|
EP1479695B1
(en)
|
2003-05-14 |
2010-02-17 |
Kenta Biotech AG |
Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa
|
|
CN1324049C
(zh)
|
2003-08-04 |
2007-07-04 |
中国疾病预防控制中心病毒病预防控制所 |
人源抗sars冠状病毒基因工程抗体
|
|
KR100891620B1
(ko)
|
2004-04-13 |
2009-04-02 |
에프. 호프만-라 로슈 아게 |
항-ｐ-셀렉틴 항체
|
|
TW200813091A
(en)
|
2006-04-10 |
2008-03-16 |
Amgen Fremont Inc |
Targeted binding agents directed to uPAR and uses thereof
|
|
EP2043690A1
(en)
|
2006-06-12 |
2009-04-08 |
Nabi Biopharmaceuticals |
Use of alpha-toxin for treating and preventing staphylococcus infections
|
|
BRPI0807952A2
(pt)
|
2007-02-20 |
2014-06-10 |
Anaptysbio Inc |
Sistemas de hipermutação somática
|
|
ES2650224T3
(es)
|
2007-08-21 |
2018-01-17 |
Amgen, Inc. |
Proteínas de unión al antígeno C-FMS humano
|
|
EP2185190B1
(en)
|
2007-08-31 |
2015-06-24 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
|
CN102171247A
(zh)
|
2008-07-02 |
2011-08-31 |
特鲁比昂药品公司 |
TNF-α拮抗剂多靶点结合蛋白
|
|
EP2208787A1
(en)
|
2009-01-19 |
2010-07-21 |
Université de Liège |
A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
|
|
CN104119438A
(zh)
|
2009-01-29 |
2014-10-29 |
米迪缪尼有限公司 |
延长体内半衰期的人抗il-6抗体及其在治疗肿瘤、自身免疫性疾病和炎症性疾病中的应用
|
|
RU2677140C1
(ru)
|
2010-05-05 |
2019-01-15 |
Нью-Йорк Юниверсити |
Лейкоцидины staphylococcus aureus, терапевтические композиции и их применение
|
|
EP3470526A3
(en)
|
2011-02-08 |
2019-07-17 |
Medimmune, LLC |
Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
|
|
US9845348B2
(en)
|
2012-11-06 |
2017-12-19 |
Medimmune, Llc |
Methods of treating S. aureus-associated diseases
|
|
MX375324B
(es)
|
2012-11-06 |
2025-03-06 |
Medimmune Llc |
Anticuerpos contra determinantes de la superficie de s. aureus.
|
|
EP3057989A1
(en)
|
2013-10-17 |
2016-08-24 |
ARSANIS Biosciences GmbH |
Cross-reactive staphylococcus aureus antibody sequences
|
|
EP3142700B1
(en)
|
2014-05-16 |
2021-03-03 |
Medimmune, LLC |
Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
|
|
TWI719938B
(zh)
|
2014-06-19 |
2021-03-01 |
美商麥迪紐有限責任公司 |
多重細菌感染之治療
|
|
MX2017012775A
(es)
*
|
2015-04-17 |
2019-04-29 |
Arsanis Biosciences Gmbh |
Preparacion combinatoria de anticuerpos anti-staphylococcus aureus.
|
|
US20190077851A1
(en)
|
2015-10-30 |
2019-03-14 |
Bruno Francois |
Methods of using anti-alpha toxin antibody
|
|
TWI902669B
(zh)
|
2018-07-24 |
2025-11-01 |
美商麥迪紐有限責任公司 |
抗金黃色葡萄球菌凝集因子a(clfa)之抗體
|
|
CN113164602A
(zh)
|
2018-10-09 |
2021-07-23 |
免疫医疗有限责任公司 |
抗金黄色葡萄球菌抗体的组合
|
|
MX2021004114A
(es)
|
2018-10-09 |
2021-07-16 |
Medimmune Llc |
Anticuerpos dirigidos contra leucotoxinas de staphylococcus aureus.
|